Opinion
Harm minimisation efforts pay big dividends
It’s time for pharmacists to speak up about the benefits of harm minimisation, writes Angelo Pricolo Many issues were discussed at the 2 March 2016 Drug Summit organised by the …
Listing ‘specialised’ pharmacies for GP direct referral – is it the same as channelling?
Lists for GPs of specialised pharmacies could set some worrying precedents, writes Jarrod McMaugh The relationship between a patient, their doctor, and their pharmacist is a complex system made up …
It’s time for a revolution
The community pharmacy revolution is here. Join now or run away, warns Mouhamad Zoghbi The community pharmacy is fighting to survive. Aggressive price disclosures cost the average pharmacy $90,000 in …
Your contribution to antimicrobial resistance
Your trash—someone else’s treasure? Not necessarily, write Judith A Singleton, Esther TL Lau and Lisa M Nissen What if we told you the antibiotics your patients threw in the garbage …
Why a good pharmacy is like a netball team
A good pharmacy manager acts as a coach for his or her pharmacy team, writes former Queensland Firebird Karen Brown If you were to ask my team (actually, if you …
Two quick ways to stay motivated
There’s a lot of negativity in the profession at the moment—so how can pharmacists stay motivated? writes Vanessa Lontos Like many pharmacists, a few weeks ago I returned from four …
The King’s speech: the difference between economists and pharmacists
Every King has his Achilles heel, writes Mouhamad Zoghbi… economists and health professionals are degrees apart This king stood with a confidence that shook the pharmacy nation. He didn’t stutter …
What’s your pharmacy’s secret sauce?
Pharmacies will never be able to get ahead without a real point of difference, writes John Cao One lesson that I have taken away from watching the many episodes of …
Don’t choose between discounts and service
Pharmacy no longer need be a ‘discount’ or ‘service’ model. The new ‘optimal pharmacy’ model optimises profits and health outcomes, writes Mouhamad Zoghbi The general consensus between today’s pharmacy leaders …
Direct-to-consumer S3 advertising: it’s time
It’s time to get serious about direct-to-consumer advertising of S3 products, ortherwise known as Pharmacist Only medications, says Dr Deon Schoombie.
Placebos: beneficial, or deceptive?
Are placebos a legitimate tool in helping patients, or is their use unethical or deceptive? wonders Ben Basger The word “placebo” is Latin for “I will please”. Pleasing patients seems …
Practice incentives for pharmacists in general practice: is it time to take the leap?
Manya Angley takes a look at the pharmacist role in general practice—and the road ahead The Australian Commission on Safety and Quality in Health Care (ACSQHC) concluded that 2%–3% of …